Research Sections

Section of Early Detection and Prevention

Cancer prevention and early detection through primary prevention and screening are among the key components of cancer control which, in turn, can lead to a decrease in cancer incidence and mortality in the population. This goes along with the development and implementation of quality assurance guidelines in order to assure highly accurate screening and effective prevention programmes.

Cancer prevention and early detection are key elements of the Agency's agenda: elucidating the natural history of cancer; providing scientific evidence on the validity, effectiveness and cost-effectiveness of prevention, screening and early diagnosis approaches; catalyzing the wider implementation of evidence-based primary and secondary prevention strategies for common cancers; addressing the factors determining population participation in prevention programmes; developing international networks; and contributing to cancer control in general.

The Section comprises three Groups, namely the Prevention and Implementation Group, the Quality Assurance Group and the Screening Group. Research projects are conducted in low- and medium-resource countries in Africa, Asia and Central and South America as well as in Europe, and focus on the prevention and early detection of cervix, breast, head and neck, stomach, colorectal and anal cancers.

The Section receives funding from, among others, the Bill & Melinda Gates Foundation, USA, the European Commission, the Union for International Cancer Control (UICC) and the National Cancer Institute, USA.